Skip to main content
. 2020 Apr 7;2020:3908641. doi: 10.1155/2020/3908641

Figure 1.

Figure 1

Study protocol. Part I: neonatal rat cardiomyocytes were subjected to OGD/R, and rats underwent myocardial I/R. Part II: the p38 MAPK inhibitor (SB203580) was used 1 h prior to OGD in cells or before myocardial ischemia in rats. Part III: cells were transfected with Hsp70 shRNA for 48 h and treated with SB203580 1 h prior to OGD, and rats received Quercetin (an Hsp70 inhibitor) and SB203580 1 h prior to myocardial ischemia. OGD/R: oxygen-glucose deprivation/reoxygenation; I/R: ischemia/reperfusion.